Drug intelligence / Profile preview

cord blood unit

Development stage
Approved
Lead developer
New York Blood Center
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Cord blood unit refers to a discrete collection of blood obtained from the umbilical cord and placenta after a baby is born. This blood is rich in **hematopoietic stem and progenitor cells**, as well as mesenchymal stem cells, making it a valuable source for stem cell transplantation and regenerative therapies. The primary mechanism involves stem cell engraftment, where transplanted cells from the cord blood unit restore hematopoiesis and immune function in recipients, especially after chemotherapy or in cases of blood, immune, or metabolic disorders. Cord blood units are stored in public or private cord blood banks and are used both for **autologous** (self) and **allogeneic** (donor to recipient) transplants. Clinical indications include **leukemia, lymphoma, sickle cell anemia, thalassemia, and inherited metabolic and immunologic diseases**. Cord blood units show unique immunological characteristics, such as tolerating more human leukocyte antigen (HLA) mismatches than bone marrow, and reduce the risk of graft-versus-host disease. They are increasingly used in research and early trials for regenerative medicine targeting neurodegenerative conditions, cerebral palsy, diabetes complications, and congenital heart disease[1][2][4][5][6][7][9][10].

Brand names
HEMACORDCLEVECORDDUCORDALLOCORD
Other names
cord bloodumbilical cord bloodumbilical cord blood unitUCB unit

Beyond the preview

Go deeper on cord blood unit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cord blood unit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call